CT angiogram monitoring of patients with cerebral aneurysms helps identify if and when the aneurysms grow, increasing the risk of rupture.
Monitoring cerebral aneurysms with CT angiogram permits physicians to watch for lesion growth regardless of the original size, allowing for quick intervention if necessary, according to a study published online in the journal Radiology.
Current guidelines suggest that known aneurysms that are smaller than seven millimeters do not need to be monitored with imaging because they are considered to be at low risk for rupturing. To assess if this recommendation was valid, researchers from the David Geffen School of Medicine at the University of California, Los Angeles, sought to identify the risk factors for cerebral aneurysm ruptures.
The researchers, led by J. Pablo Villablanca, MD, chief of diagnostic neuroradiology, studied 165 asymptomatic patients (132 women, 33 men) who had been discovered to have cerebral aneurysms either incidentally or during a baseline study. A total of 258 aneurysms were identified. The patients underwent CT angiography every six or 12 months for a mean of 2.24 years.
The images showed growth in 46 of all intracranial aneurysms in 38 patients. Three of the 39 growing saccular aneurysms ruptured, and of those, all were smaller than seven millimeters in size at study entry.
Compared to the aneurysms that stayed the same size, the 46 growing aneurysms were associated with a 12-fold higher risk of rupture. The researchers calculated the risk of rupture for growing aneurysms at 2.4 percent per patient-year versus 0.2 percent for aneurysms that did not grow.
“The positive association between aneurysm growth, aneurysm size, and cigarette smoking suggests that the combination of these factors are associated with an increased risk of rupture and may influence the need for therapeutic intervention,” Villablanca said in a release.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.